
Thomas Sweeney Heard
Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1286 |
| Issued Applications | 710 |
| Pending Applications | 90 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10961557
[patent_doc_number] => 20140364587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'Dipeptide Comprising a Non-Proteogenic Amino Acid'
[patent_app_type] => utility
[patent_app_number] => 14/368465
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12797
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368465 | Dipeptide Comprising a Non-Proteogenic Amino Acid | Dec 19, 2012 | Abandoned |
Array
(
[id] => 9174956
[patent_doc_number] => 20130316941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'GLUCAGON ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/720041
[patent_app_country] => US
[patent_app_date] => 2012-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12003
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13720041
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/720041 | GLUCAGON ANALOGUES | Dec 18, 2012 | Abandoned |
Array
(
[id] => 10459519
[patent_doc_number] => 20150344534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 14/363565
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14048
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/363565 | OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS | Dec 6, 2012 | Abandoned |
Array
(
[id] => 8768240
[patent_doc_number] => 20130096277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'PROCESSES AND INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 13/692565
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11866
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 48
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692565
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/692565 | PROCESSES AND INTERMEDIATES | Dec 2, 2012 | Abandoned |
Array
(
[id] => 10912801
[patent_doc_number] => 20140315818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'METHODS AND PRODUCTS FOR TREATING PREECLAMPSIA AND MODULATING BLOOD PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 14/362157
[patent_app_country] => US
[patent_app_date] => 2012-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15342
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/362157 | Methods and products for treating preeclampsia and modulating blood pressure | Nov 29, 2012 | Issued |
Array
(
[id] => 10912791
[patent_doc_number] => 20140315809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'CALCIMIMETICS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/357702
[patent_app_country] => US
[patent_app_date] => 2012-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22454
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357702
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/357702 | CALCIMIMETICS AND METHODS FOR THEIR USE | Nov 11, 2012 | Abandoned |
Array
(
[id] => 8708672
[patent_doc_number] => 20130065961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'MODULATION OF PHYSIOLOGICAL PROCESSES AND AGENTS USEFUL FOR SAME'
[patent_app_type] => utility
[patent_app_number] => 13/673327
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11513
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673327
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/673327 | MODULATION OF PHYSIOLOGICAL PROCESSES AND AGENTS USEFUL FOR SAME | Nov 8, 2012 | Abandoned |
Array
(
[id] => 8697996
[patent_doc_number] => 20130060005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL'
[patent_app_type] => utility
[patent_app_number] => 13/668388
[patent_app_country] => US
[patent_app_date] => 2012-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15156
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/668388 | COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL | Nov 4, 2012 | Abandoned |
Array
(
[id] => 10533860
[patent_doc_number] => 09259477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-16
[patent_title] => 'GLP-1 receptor agonist peptide gastrin conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/355906
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 17506
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355906 | GLP-1 receptor agonist peptide gastrin conjugates | Nov 1, 2012 | Issued |
Array
(
[id] => 10925778
[patent_doc_number] => 20140328799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/355363
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12418
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355363
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355363 | COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | Oct 25, 2012 | Abandoned |
Array
(
[id] => 10912813
[patent_doc_number] => 20140315831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'Synthesis of Libraries of Peptide Tertiary Amides'
[patent_app_type] => utility
[patent_app_number] => 14/354031
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16918
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354031
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354031 | Synthesis of libraries of peptide tertiary amides | Oct 24, 2012 | Issued |
Array
(
[id] => 9896064
[patent_doc_number] => 20150051262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'NMDA RECEPTOR MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/353681
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 55985
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353681
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353681 | NMDA RECEPTOR MODULATORS AND USES THEREOF | Oct 23, 2012 | Abandoned |
Array
(
[id] => 9719609
[patent_doc_number] => 20140255309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Peptide for Synthesizing Silica, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/348322
[patent_app_country] => US
[patent_app_date] => 2012-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12198
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348322
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348322 | Peptide capable of silica deposition and use thereof | Oct 1, 2012 | Issued |
Array
(
[id] => 10953264
[patent_doc_number] => 20140356285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'COMPOSITIONS AND METHODS RELATED TO TISSUE TARGETING'
[patent_app_type] => utility
[patent_app_number] => 14/346421
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32440
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346421
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346421 | COMPOSITIONS AND METHODS RELATED TO TISSUE TARGETING | Sep 19, 2012 | Abandoned |
Array
(
[id] => 12305886
[patent_doc_number] => 09938328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
[patent_app_type] => utility
[patent_app_number] => 14/428843
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 10644
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428843
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428843 | Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation | Sep 16, 2012 | Issued |
Array
(
[id] => 8612679
[patent_doc_number] => 20130017991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/620573
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 39150
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620573
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620573 | HCV protease inhibitors and uses thereof | Sep 13, 2012 | Issued |
Array
(
[id] => 10968099
[patent_doc_number] => 20140371131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'ADHESIVE BIOPOLYMERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/342392
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25729
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342392 | Adhesive biopolymers and uses thereof | Aug 29, 2012 | Issued |
Array
(
[id] => 8523326
[patent_doc_number] => 20120322734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'Pharmaceutical Compositions Including Low Dosages of Desmopressin'
[patent_app_type] => utility
[patent_app_number] => 13/599768
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14242
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13599768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/599768 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | Aug 29, 2012 | Abandoned |
Array
(
[id] => 8685294
[patent_doc_number] => 20130053577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/598430
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67145
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13598430
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/598430 | Antiviral compounds | Aug 28, 2012 | Issued |
Array
(
[id] => 10389775
[patent_doc_number] => 20150274781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'POTENT LIGANDS OF THE GHRELIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 14/240829
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14579
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240829
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240829 | Potent ligands of the ghrelin receptor | Aug 23, 2012 | Issued |